Clinical Trials Browser

Phase 1 × Prostatic Neoplasms, Castration-Resistant × darolutamide × Clear all

NCT05997615 2026-02-24

AMX-500

Phase 1 Recruiting

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT05519449 2026-01-20

ENGAGER-PSMA-01

Phase 1 Recruiting

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant